Category: Bio/Pharma/CRO
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more
Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents
Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents Read more
Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutic development
Waltham, MA, October 13, 2022 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB. The move will add new global talent to Cytel’s Strategic Consulting group and bring additional expertise and capabilities for the... Read more
Agilent Opens Center of Excellence for Dissolution Products
SANTA CLARA, Calif., October 12, 2022 Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution... Read more